EUVIMEDEUVIMED entdecken
Crossref

Lactate-driven lysine lactylation in tumor progression, therapy resistance, and prognosis

Dan Huang, Lan Jiang, Qihui Zhao, Zhe Chen

MedScience · 2026-04 · 20 (2) · 392-395

DOI: 10.1007/s11684-026-1212-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedScience, online erschienen am 30.04.2026. Verfasst von Dan Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Hunan Polytechnic of Environment and Biology, Hengyang, 421005, China. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • School of Medicine, Hunan Polytechnic of Environment and Biology, Hengyang, 421005, China.
  • School of Medicine, Hunan Polytechnic of Environment and Biology, Hengyang, 421005, China. 122322157@qq.com.
  • Institute of Pharmacy and Pharmacology, College of Pharmacy, University of South China, Hengyang, 421001, China. 2023002046@usc.edu.cn.

Zitieren

APA

Huang, D., Jiang, L., Zhao, Q., & Chen, Z. (2026). Lactate-driven lysine lactylation in tumor progression, therapy resistance, and prognosis. MedScience, 20(2), 392-395. https://doi.org/10.1007/s11684-026-1212-4

Vancouver

Huang D, Jiang L, Zhao Q, Chen Z. Lactate-driven lysine lactylation in tumor progression, therapy resistance, and prognosis. MedScience. 2026;20(2):392-395. doi:10.1007/s11684-026-1212-4

BibTeX
@article{Huang2026,
  author = {Huang, Dan and Jiang, Lan and Zhao, Qihui and Chen, Zhe},
  title = {Lactate-driven lysine lactylation in tumor progression, therapy resistance, and prognosis},
  journal = {MedScience},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {392--395},
  doi = {10.1007/s11684-026-1212-4}
}
Kostenlos starten →